COVID-19 vaccine hesitancy: Lessons from Israel.
作者信息
Gurwitz David
机构信息
Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
出版信息
Vaccine. 2021 Jun 29;39(29):3785-3786. doi: 10.1016/j.vaccine.2021.05.085. Epub 2021 May 27.
Abstract
摘要
相似文献
1
COVID-19 vaccine hesitancy: Lessons from Israel.新冠疫苗犹豫：来自以色列的经验教训。
Vaccine. 2021 Jun 29;39(29):3785-3786. doi: 10.1016/j.vaccine.2021.05.085. Epub 2021 May 27.
2
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
3
Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel.BNT162b2 疫苗加强针对 SARS-CoV-2 感染和突破感染并发症的有效性，以色列。
Emerg Infect Dis. 2022 May;28(5):948-956. doi: 10.3201/eid2805.220141. Epub 2022 Apr 1.
4
Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.以色列卫生保健工作者中，第三剂 BNT162b2 疫苗接种与 SARS-CoV-2 感染发生率的关联。
JAMA. 2022 Jan 25;327(4):341-349. doi: 10.1001/jama.2021.23641.
5
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.在以色列全国范围内使用辉瑞-生物科技公司的 BNT162b2 mRNA COVID-19 疫苗进行疫苗接种运动，以预防感染、住院和死亡：一项回顾性监测研究。
Lancet Infect Dis. 2022 Mar;22(3):357-366. doi: 10.1016/S1473-3099(21)00566-1. Epub 2021 Sep 22.
6
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.BNT162b2 疫苗接种与医护人员中出现有症状和无症状 SARS-CoV-2 感染的相关性。
JAMA. 2021 Jun 22;325(24):2457-2465. doi: 10.1001/jama.2021.7152.
7
Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine.青少年接种辉瑞-生物科技新冠疫苗后的心肌炎。
J Pediatric Infect Dis Soc. 2021 Nov 11;10(10):962-966. doi: 10.1093/jpids/piab060.
8
9
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine.辉瑞-生物科技（BNT162b2） COVID-19 疫苗加强针接种后对 SARS-CoV-2 奥密克戎变异株的中和能力增强。
Viruses. 2022 Sep 13;14(9):2023. doi: 10.3390/v14092023.
10
Humoral and cellular immune responses to Pfizer-BioNTech BNT162b2 SARS-CoV-2 vaccine in adolescents with liver transplantation: Single center experience.青少年肝移植患者对辉瑞-生物科技 BNT162b2 SARS-CoV-2 疫苗的体液和细胞免疫反应：单中心经验。
Front Immunol. 2022 Nov 23;13:1049188. doi: 10.3389/fimmu.2022.1049188. eCollection 2022.
引用本文的文献
1
Vaccine Hesitancy and the Concept of Trust: An Analysis Based on the Israeli COVID-19 Vaccination Campaign.疫苗犹豫与信任概念：基于以色列新冠疫苗接种运动的分析
Minerva. 2023 Jun 10:1-25. doi: 10.1007/s11024-023-09498-9.
2
Editorial: COVID-19 pandemics: Ethical, legal and social issues.社论：COVID-19大流行：伦理、法律和社会问题。
Front Genet. 2022 Nov 29;13:1021865. doi: 10.3389/fgene.2022.1021865. eCollection 2022.
3
Informed Consent in Mass Vaccination against COVID-19 in Romania: Implications of Bad Management.罗马尼亚大规模新冠疫苗接种中的知情同意：管理不善的影响
Vaccines (Basel). 2022 Nov 5;10(11):1871. doi: 10.3390/vaccines10111871.
4
Rapid Rollout and Initial Uptake of a Booster COVID-19 Vaccine Among Israel Defense Forces Soldiers.以色列国防军士兵中 COVID-19 加强疫苗的快速推出和初步接种。
J Prev (2022). 2023 Feb;44(1):1-14. doi: 10.1007/s10935-022-00702-2. Epub 2022 Aug 16.
5
Assessing the influence of French vaccine critics during the two first years of the COVID-19 pandemic.评估法国新冠疫情大流行的头两年中疫苗批评者的影响。
PLoS One. 2022 Aug 4;17(8):e0271157. doi: 10.1371/journal.pone.0271157. eCollection 2022.
6
Impact of societal resilience on vaccine hesitancy and uptake: Lessons learned from the Israeli experience.社会复原力对疫苗犹豫和接种率的影响：从以色列经验中汲取的教训。
Int J Disaster Risk Reduct. 2022 Sep;79:103181. doi: 10.1016/j.ijdrr.2022.103181. Epub 2022 Jul 19.
7
Public perceptions and the willingness to get vaccinated against COVID-19: Lessons from Israel.公众认知与接种 COVID-19 疫苗意愿：来自以色列的经验教训。
Vaccine. 2022 Mar 18;40(13):2053-2061. doi: 10.1016/j.vaccine.2022.02.031. Epub 2022 Feb 11.
8
COVID-19 Among Youth in Israel: Correlates of Decisions to Vaccinate and Reasons for Refusal.以色列青少年中的 COVID-19：疫苗接种决策的相关因素和拒绝接种的原因。
J Adolesc Health. 2022 Mar;70(3):396-402. doi: 10.1016/j.jadohealth.2021.11.016. Epub 2021 Nov 24.
9
Addressing vaccine hesitancy and access barriers to achieve persistent progress in Israel's COVID-19 vaccination program.解决疫苗犹豫和获取障碍，以实现以色列 COVID-19 疫苗接种计划的持续进展。
Isr J Health Policy Res. 2021 Aug 2;10(1):43. doi: 10.1186/s13584-021-00481-x.
本文引用的文献
1
WHO's allocation framework for COVAX: is it fair?世卫组织的新冠疫苗实施计划（COVAX）分配框架：公平吗？
J Med Ethics. 2022 Jul;48(7):434-438. doi: 10.1136/medethics-2020-107152. Epub 2021 Apr 9.
2
Fight against hesitancy: public health concern towards COVID-19 vaccine.消除犹豫：公众对新冠病毒疫苗的公共卫生关注
J Public Health (Oxf). 2021 Jun 7;43(2):e372. doi: 10.1093/pubmed/fdab084.
3
Signals of hope: gauging the impact of a rapid national vaccination campaign.希望的信号：评估全国快速疫苗接种运动的影响。
Nat Rev Immunol. 2021 Apr;21(4):198-199. doi: 10.1038/s41577-021-00531-0.
4
Covid-19 vaccine hesitancy among ethnic minority groups.少数族裔群体对新冠疫苗的犹豫态度。
BMJ. 2021 Feb 26;372:n513. doi: 10.1136/bmj.n513.
5
Vaccines are curbing COVID: Data from Israel show drop in infections.疫苗正在遏制新冠疫情：以色列的数据显示感染人数下降。
Nature. 2021 Feb;590(7845):197. doi: 10.1038/d41586-021-00316-4.
6
Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom.爱尔兰和英国与新冠疫苗犹豫及抵触相关的心理特征。
Nat Commun. 2021 Jan 4;12(1):29. doi: 10.1038/s41467-020-20226-9.
7
Age, ageing, ageism and "age-itation" in the Age of COVID-19: rights and obligations relating to older persons in Israel as observed through the lens of medical ethics.新冠疫情时代的年龄、老龄化、年龄歧视与“年龄焦虑”：从医学伦理视角审视以色列老年人的权利与义务
Isr J Health Policy Res. 2020 Nov 12;9(1):64. doi: 10.1186/s13584-020-00416-y.
8
Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust.评估与部署新冠疫苗——透明度、科学诚信及公众信任的重要性
N Engl J Med. 2020 Oct 29;383(18):1703-1705. doi: 10.1056/NEJMp2026393. Epub 2020 Sep 23.
9
Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.急于推出新冠病毒疫苗的不良后果：对公众信任的影响。
JAMA. 2020 Jun 23;323(24):2460-2461. doi: 10.1001/jama.2020.8917.
10
A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation.未来针对新冠病毒的疫苗接种运动面临疫苗犹豫和政治化的风险。
Lancet Infect Dis. 2020 Jul;20(7):769-770. doi: 10.1016/S1473-3099(20)30426-6. Epub 2020 May 20.
Zotero 插件